BackWho do joints hurt?
It is not always easy and quick to identify the cause of joint pain.
Antibodies to cyclic citrullinated peptide (ACCP) - a new modern diagnostic method in rheumatology.
Determination of ACCP allows a more reliable diagnosis of such a serious disease as Rheumatoid Arthritis.
The earlier the cause of joint inflammation is identified, the better the chances of halting the progression of the disease and preventing disabilities.
Antibodies to cyclic citrullinated peptide are highly specific for Rheumatoid arthritis. ACCPs appear at the very early stage of the disease and even 1 year before the onset of clinical manifestations of arthritis (pain, swelling, joint stiffness, etc.).
Rheumatoid arthritis affects about 1% of the population. It is the most common autoimmune disease in which inflammation in the joints leads to joint damage, destruction and loss of function. Unfortunately, without treatment, joint deformities develop quickly and internal organs become affected. These patients are treated by rheumatologists, who usually see patients in advanced stages of disease.
The determination of ACCP is particularly important in the case of a negative result for Rheumatoid Factor and an unclear cause of arthritis.
Early diagnosis of Rheumatoid arthritis and immediate initiation of proper treatment is the key to preventing joint destruction and prolonging active longevity.
So if you have joint pain, visit a doctor and get an ACCP test if necessary.